The Phase 3 SURMOUNT trials, which enrolled over 6,000 participants, did not exclude patients taking antioxidant supplements (including glutathione precursors like N-acetylcysteine)
Medical evidence suggests that for chronic weight management conditions, GLP-1 therapy functions similarly to other chronic medicationsdiscontinuation often requires maintenance or lifestyle backup
Variants in genes like FTO and MC4R may influence your individual response to GLP-1 therapy and digestive side effects
Dive into the evolution of GLP-1 use New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more As the demand for glucagon-like peptide-1 (GLP-1) agonist medications for weight loss continues to climb, Prime Therapeutics (Prime) is uniquely positioned to manage this rapidly evolving drug class
Let us understand what are these marks and how to treat them effectively
Silveira D, Prieto-Garcia JM, Boylan F, Estrada O, Fonseca-Bazzo YM, Jamal CM, et al
